Antiviral Docking: Neuraminidase, HIV Protease, HBV and HCV Targets

By BioDockify Computational Research Team · September 23, 2026 · Disease Applications

Antiviral docking targets — influenza neuraminidase (oseltamivir control), HIV protease and integrase, HBV polymerase, HCV NS3 — controls, repurposing angles, and mutation caveats.

Read the complete article with tables, code and references on BioDockify.

Key References

• Pushpakom, S. et al. Drug repurposing: progress, challenges, and recommendations. Nat. Rev. Drug Discov. 18, 41-58 (2019).
• Ferreira, L.G. et al. Molecular docking and structure-based drug design strategies. Molecules 20, 13384-13421 (2015).

Scope & Limitations

Viral mutation rates undermine static-target reasoning Intracellular exposure requirements complicate interpretation